On the other hand, the fact that Ffar2 (GPR43)-deficient (Ffar2-KO) mice are completely protected from high-fat diet-induced obesity, dyslipidemia, and fatty liver [92] supports the importance of SCFAs/GPR43 signaling in the development of NAFLD. This evidence concerns the gene FFAR2 and metabolic syndrome.